T. Rowe Price Associates’s Whitehawk Therapeutics, Inc. Common Stock WHWK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-10,692
| Closed | -$26K | – | 3049 |
|
|
2024
Q1 | $26K | Hold |
10,692
| – | – | ﹤0.01% | 2922 |
|
|
2023
Q4 | $22K | Sell |
10,692
-200,000
| -95% | -$412K | ﹤0.01% | 2868 |
|
|
2023
Q3 | $1.02M | Sell |
210,692
-17,705
| -8% | -$85.7K | ﹤0.01% | 1783 |
|
|
2023
Q2 | $1.56M | Sell |
228,397
-9,332
| -4% | -$63.9K | ﹤0.01% | 1576 |
|
|
2023
Q1 | $1.72M | Sell |
237,729
-7,514
| -3% | -$54.4K | ﹤0.01% | 1514 |
|
|
2022
Q4 | $3.15M | Sell |
245,243
-6,036
| -2% | -$77.4K | ﹤0.01% | 1299 |
|
|
2022
Q3 | $3.55M | Buy |
251,279
+4,041
| +2% | +$57.1K | ﹤0.01% | 1266 |
|
|
2022
Q2 | $3.05M | Sell |
247,238
-188,713
| -43% | -$2.32M | ﹤0.01% | 1499 |
|
|
2022
Q1 | $7.4M | Sell |
435,951
-72,941
| -14% | -$1.24M | ﹤0.01% | 1409 |
|
|
2021
Q4 | $12.3M | Buy |
508,892
+43,293
| +9% | +$1.05M | ﹤0.01% | 1378 |
|
|
2021
Q3 | $13M | Buy |
465,599
+448,686
| +2,653% | +$12.5M | ﹤0.01% | 1390 |
|
|
2021
Q2 | $429K | Hold |
16,913
| – | – | ﹤0.01% | 2449 |
|
|
2021
Q1 | $327K | Buy |
+16,913
| New | +$327K | ﹤0.01% | 2528 |
|